REGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES. R e g i S C A R PATIENT'S DATA. Age country of birth

Size: px
Start display at page:

Download "REGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES. R e g i S C A R PATIENT'S DATA. Age country of birth"

Transcription

1 REGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES R e g i S C A R PATIENT'S DATA Initials of the patient date of birth Age country of birth Gender male female Death before interview no Participation agreed to by the patient registry yes cohort study (only for DRESS) genetic study

2 - 2 - HOSPITAL DATA Reporting hospital / department hospital no. date of admission Treating hospital / department hospital no. date of admission date of notification date of interview Transfer from one or more hospitals to the reporting / treating hospital: no yes unknown first hospital: hospital no. date of admission Retrospective assessment no yes Development of skin reaction prior to admission during inhospital stay

3 - 3 - DIAGNOSES AND CLINICAL COURSE Admission diagnoses 1) 2) 3) Date Clinical symptoms Fever date of onset date of normalization* highest temperature ( C) method of measurement * if cured before admission

4 - 4 B - FOR CASES OF AGEP ONLY SKIN SYMPTOMS Subjective symptoms Burning date of onset date of resolution* Pain Pruritus Erythema, exanthema - diffuse erythema localization of exanthema: - urticarial mainly folds - maculopapular widespread - purpura face - target lesions other: - other: - unknown unknown Maximum extent of exanthema (percentage related to the BSA) Facial edema date of onset date of resolution* * if cured before discharge / death of patient (if information of grey marked fields could not observed before discharge please try to verify information via phone call)

5 - 5 B - FOR CASES OF AGEP ONLY Pustules - few (< 25) - many (> 25; dozens) - unknown date of onset date of resolution* Type of pustules: - follicular - non-follicular - unknown type of pustules Localization of pustules: - mainly folds - folds spared - widespread - face - other: - unknown Blisters / epidermal sheets > 5cm date of onset date of resolution* Maximum of detachment (percentage related to the BSA) Postpustular desquamation date of onset date of resolution* * if cured before discharge / death of patient (if information of grey marked fields could not observed before discharge please try to verify information via phone call)

6 - 6 B FOR CASES OF AGEP ONLY MUCOSAL EROSIONS Lips date of onset date of resolution* Mouth Eyes Genital Anal Nasal LABORATORY FINDINGS - Leucocytes On admission: /?l not done Maximum: /?l date of maximum - Neutrophils On admission: /?l not done Maximum: /?l date of maximum - Eosinophils not done On admission: /?l date of maximum Maximum: /?l - Pathological renal-function highest pathological values: _ - Pathological liver-function highest pathological values: _ * if cured before discharge / death of patient

7 - 7 - FOR ALL CASES FURTHER INFORMATION FOR CASE VALIDATION Photographs date of first occurrence Biopsy Diagnosis by a dermatologist please specify: Further photographs / biopsies and comments: Date Notes

8 - 8 - SYMPTOMS / EVENTS WITHIN 1 MONTH BEFORE THE RECENT SKIN REACTION Herpes labialis or fever blisters date of onset date of normalization* Do you have recurrent herpes labialis or fever blisters? date of last eruption Herpes genitalis date of onset date of normalization* Do you have recurrent genital herpes? date of last eruption *if cured before admission

9 - 9 - SYMPTOMS / EVENTS WITHIN 1 MONTH BEFORE THE RECENT SKIN REACTION Infections - influenza / influenza-like illness date of onset date of normalization* Was the diagnosis confirmed by a physician? Was any diagnostic test performed? Was any medication taken for treatment? - respiratory tract infection Was the diagnosis confirmed by a physician? Was any diagnostic test performed? Was any medication taken for treatment? - urinary tract infection Was the diagnosis confirmed by a physician? Was any diagnostic test performed? Was any medication taken for treatment? - other infection 1 Was the diagnosis confirmed by a physician? Was any diagnostic test performed? Was any medication taken for treatment? - other infection 2 *if cured before admission Was the diagnosis confirmed by a physician? Was any diagnostic test performed? Was any medication taken for treatment? HIV-status HIV AIDS (current status) If yes for HIV or AIDS, most recent CD4 count per?l: *if cured before admission

10 HAVE YOU HAD ANY OF THE FOLLOWING DISEASES THAT ARE STILL ACTIVE? Severe liver disorders year of event Severe kidney disorders year of event Rheumatic / collagen-vascular disease - rheumatoid polyarthritis year of event - systemic lupus erythematosus - other: Was a first-degree family member diagnosed with any rheumatic/ collagen-vascular disease? Inflammatory bowel disease - Colitis ulcerosa year of event - Crohn's disease Psoriasis year of event - Pustular psoriasis, generalized Was a first-degree family member diagnosed with psoriasis? Convulsive disorder / epilepsy year of event

11 HAVE YOU BEEN DIAGNOSED WITH A MALIGNANT DISEASE/CANCER WITHIN THE LAST 2 YEARS BEFORE THE REACTION OR THAT IS STILL BEING TREATED? Malignant diseases / cancer please specify: year of event please specify: HAVE YOU HAD ANY RADIOTHERAPY RECENTLY? Have you ever had X-ray or radiotherapy? (not UV-radiation) for what indication? date of most recent therapy - lymphoma - brain tumor - other reason: HAVE YOU IN THE PAST HAD ANY TRANSPLANTATION? year of transplantation Transplantation - Stem cell - other: _ HAVE YOU IN THE PAST HAD ANY SCAR? year of event SCAR please specify:

12 medication sheet no. of Interview no MEDICATION HISTORY WITHIN 1 MONTH BEFORE HOSPITALIZATION date of admission drug use Drug Indication Type of application Dose Begin of intake End of intake Frequency day month year day month year previous intake any adverse reaction please specify: Drug Indication Type of application Dose Begin of intake End of intake Frequency day month year day month year previous intake any adverse reaction please specify: Drug Indication Type of application Dose Begin of intake End of intake Frequency day month year day month year previous intake any adverse reaction please specify:

13 medication sheet no. of Interview no MEDICATION HISTORY WITHIN 1 MONTH BEFORE HOSPITALIZATION date of admission drug use Drug Indication Type of application Dose Begin of intake End of intake Frequency day month year day month year previous intake any adverse reaction please specify: Drug Indication Type of application Dose Begin of intake End of intake Frequency day month year day month year previous intake any adverse reaction please specify: Drug Indication Type of application Dose Begin of intake End of intake Frequency day month year day month year previous intake any adverse reaction please specify:

14 medication sheet no. of Interview no MEDICATION HISTORY WITHIN 1 MONTH BEFORE HOSPITALIZATION date of admission drug use Drug Indication Type of application Dose Begin of intake End of intake Frequency day month year day month year previous intake any adverse reaction please specify: Drug Indication Type of application Dose Begin of intake End of intake Frequency day month year day month year previous intake any adverse reaction please specify: Drug Indication Type of application Dose Begin of intake End of intake Frequency day month year day month year previous intake any adverse reaction please specify:

15 Have you ever had a rash / skin reaction suspected to be an adverse reaction to a drug? Drug: Type of eruption: Drug: Type of eruption: Drug: Type of eruption: Drug: Type of eruption: Drug: Type of eruption:

16 DISCHARGE SHEET Discharge diagnoses Results of the present admission 1. Death 2. Discharge date of death date of discharge Mycoplasma infection within two months before admission date of diagnosis If no or yes, by which diagnostic means was the diagnosis reached: serology isolation x-ray PCR unknown

17 MAIN SOURCE OF INFORMATION 1) Clinical pattern of the reaction * Were the skin lesions seen by the investigator in acute stage? If not, please provide the source (e.g., family physician, dermatologist, nurse, family member) 2) Medication history * just patient * just other source please specify: * both please specify:

18 ADDITIONAL REMARKS (optional) Please use the fields below to note important additional information. Please stick to the predefined topics and avoid redundancy: Here you can specify additional information regarding ethnic origin: Here you can indicate if patient died after discharge. Please provide date of death: Death date Here you can specify any other reason why follow-up investigations (DRESS) /blood sampling (SJS/TEN) could not be done: Further relevant remarks:

19 FOR CASES OF AGEP ONLY THERAPY UNIT OF TREATMENT 1. Burn unit 2. Dept. of dermatology 3. Intensive care unit 4. Pediatric department 5. Internal medicine 6. Other: Did the patient receive any systemic treatment because of the pustular disorder (only to be completed, if not stated in the discharge letter)? SYSTEMIC THERAPY (steroids, other immunomodulating agents, IVIG, antibiotics, retinoids and anti-tnf) Brand name: Dosage: Application: p.o. i.v. Brand name: Dosage: Application: p.o. i.v. Brand name: Dosage: Application: p.o. i.v. Brand name: Dosage: Application: p.o. i.v.

Skin Manifestations of Drug Reactions

Skin Manifestations of Drug Reactions Skin Manifestations of Drug Reactions Dr Carol Hlela, Division of Dermatology Department of Medicine, University of Cape Town and Red Cross Children s Hospital What are the Skin Manifestations of Drug

More information

Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Supplementary online-material Supplementary Table S1: Detailed descriptive analysis

More information

Future of Pediatrics: Blisters, Hives and Other Tales from the Emergency Room June 14 th, 2016

Future of Pediatrics: Blisters, Hives and Other Tales from the Emergency Room June 14 th, 2016 A. Yasmine Kirkorian MD Assistant Professor of Dermatology & Pediatrics Children s National Health System George Washington University School of Medicine & Health Sciences Future of Pediatrics: Blisters,

More information

Cutaneous Drug Reactions

Cutaneous Drug Reactions Cutaneous Drug Reactions Andrei Metelitsa, MD, FRCPC, FAAD Co-Director, Institute for Skin Advancement Clinical Associate Professor, Dermatology University of Calgary, Canada Copyright 2017 by Sea Courses

More information

Drug Allergy A Guide to Diagnosis and Management

Drug Allergy A Guide to Diagnosis and Management Drug Allergy A Guide to Diagnosis and Management (Version 1 April 2015 updated April 2018) Author: Jed Hewitt Chief Pharmacist, Governance & Professional Practice Date of Preparation: April 2015 Updated:

More information

Emergency Dermatology Dr Melissa Barkham

Emergency Dermatology Dr Melissa Barkham Emergency Dermatology Dr Melissa Barkham Spotlight Seminar 30 th September 2010 Why is this important? Urgent recognition and treatment of dermatologic emergencies can be life saving and prevent long term

More information

Rashes Not To Be Missed In Children

Rashes Not To Be Missed In Children May 2016 Rashes Not To Be Missed In Children Dr Chan Yuin Chew Dermatologist Dermatology Associates Gleneagles Medical Centre Scope of presentation Focus on rashes May lead to significant morbidity if

More information

New product information wording Extracts from PRAC recommendations on signals

New product information wording Extracts from PRAC recommendations on signals 12 October 2017 EMA/PRAC/610988/2017 Pharmacovigilance Risk Assessment Committee (PRAC) New product information wording Extracts from PRAC recommendations on signals Adopted at the 25-29 September 2017

More information

Five things not to miss in Dermatology. Dr Judy Wismer Associate Clinical Professor Michael G DeGroote School of Medicine

Five things not to miss in Dermatology. Dr Judy Wismer Associate Clinical Professor Michael G DeGroote School of Medicine Five things not to miss in Dermatology Dr Judy Wismer Associate Clinical Professor Michael G DeGroote School of Medicine Key Descriptives Fever, skin pain Purpura, necrosis Bullae, Mucosal, Skin sloughing

More information

Bacterial Infections in Pediatric Dermatology. Patrick McMahon, MD Children s Hospital of Philadelphia

Bacterial Infections in Pediatric Dermatology. Patrick McMahon, MD Children s Hospital of Philadelphia Bacterial Infections in Pediatric Dermatology Patrick McMahon, MD Children s Hospital of Philadelphia Fill In The Blank When you see on the skin, you think of a bacterial skin infection SEND SWABS VIRAL

More information

DERMATOLOGICAL EMERGENCIES. DR. Ian Hoyle MBBS DIP IMC RCS (Ed), DA (UK),FRACGP,FACRRM,DIP DERM(Wales) TASMANIAN SKIN AND BODY CENTRE

DERMATOLOGICAL EMERGENCIES. DR. Ian Hoyle MBBS DIP IMC RCS (Ed), DA (UK),FRACGP,FACRRM,DIP DERM(Wales) TASMANIAN SKIN AND BODY CENTRE DERMATOLOGICAL EMERGENCIES DR. Ian Hoyle MBBS DIP IMC RCS (Ed), DA (UK),FRACGP,FACRRM,DIP DERM(Wales) TASMANIAN SKIN AND BODY CENTRE Dermatological Emergencies INFECTIONS ERYTHRODERMA DRUG ERUPTIONS STEVENS-JOHNSON

More information

To update the use of IVIG and CORTICOIDS IN management of SJS/ TEN To remind Doctors being careful when giving

To update the use of IVIG and CORTICOIDS IN management of SJS/ TEN To remind Doctors being careful when giving Present : Dr Pham Thi Minh Rang Internal Department No2-Hospital for children No2 AIMS To update the use of IVIG and CORTICOIDS IN management of SJS/ TEN To remind Doctors being careful when giving To

More information

N N N N N N N N N N N N N N N N N N N N N N N

N N N N N N N N N N N N N N N N N N N N N N N Have you ever had or are you currently experiencing any of the following? Acne Anorexia Anemia Asthma Bleeding Tendency Blood Disorder Bruising Tendency Cancer-Active Cancer- Remission Cardiac Disorder

More information

Phototherapy and Photochemotherapy Treatment (Ultraviolet A [PUVA] and B [UBV])

Phototherapy and Photochemotherapy Treatment (Ultraviolet A [PUVA] and B [UBV]) Origination: 09/27/07 Revised: 08/2/17 Annual Review: 11/2/17 Purpose: To provide Phototherapy and Photochemotherapy Treatment (PUVA and UBV) guidelines for the Medical Department staff to reference when

More information

A Retrospective Study of Spectrum of Nevirapine Induced Cutaneous Drug Reactions in HIV Positive Patients

A Retrospective Study of Spectrum of Nevirapine Induced Cutaneous Drug Reactions in HIV Positive Patients Journal of US-China Medical Science 12 (2015) 85-89 doi: 10.17265/1548-6648/2015.02.008 D DAVID PUBLISHING A Retrospective Study of Spectrum of Nevirapine Induced Cutaneous Drug Reactions in HIV Positive

More information

Vulval dermatoses. Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough

Vulval dermatoses. Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough Vulval dermatoses Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough Pigmentation Vulvodynia Ulcers Genetic Pruritus VULVAL

More information

ANTIBIOTICS ACUTE RHINOSINUSITIS IN CHILDREN

ANTIBIOTICS ACUTE RHINOSINUSITIS IN CHILDREN MARCH 2016 DRUG ANTIBIOTICS This optimal usage guide is mainly intended f primary care health professionnals. It is provided f infmation purposes only and should not replace the clinician s judgement.

More information

Past Medical History. Chief Complaint: Patient Name: Appointment Date: Page 1

Past Medical History. Chief Complaint: Patient Name: Appointment Date: Page 1 Appointment Date: Page 1 Chief Complaint: (Please write reason, symptoms, condition or diagnosis that prompts your appointment) Past Medical History PERSONAL SKIN HISTORY YES NO Yes - Details Melanoma

More information

Herbal and homeopathic products, often considered natural and non-toxic, can also cause adverse drug reactions.

Herbal and homeopathic products, often considered natural and non-toxic, can also cause adverse drug reactions. Idiosyncratic and potentially serious cutaneous adverse drug reactions (CADRs), although relatively rare, account for significant morbidity and mortality. RANNAKOE J LEHLOENYA, BSc, MB ChB, FCDerm (SA)

More information

Dermatology GP Referral Guidelines

Dermatology GP Referral Guidelines Austin Health Dermatology Department holds 5 Clinic sessions to discuss and plan the treatment of with Dermatology conditions. Department of Health clinical urgency categories for specialist clinics Urgent:

More information

=ﻰﻤاﻤﺤﻠا ﺔﻴﻘﻠﺤﻠا ﺔذﺒاﻨﻠا

=ﻰﻤاﻤﺤﻠا ﺔﻴﻘﻠﺤﻠا ﺔذﺒاﻨﻠا 1 / 15 Erythema Annulare Centrifugum and Other Figurate Erythemas The figurate erythemas include a variety of eruptions characterized by annular and polycyclic lesions. Classification of this group has

More information

IMPACT #: Local Inventory #: form 04. Age at admission: d. mo yr. Postal code:

IMPACT #: Local Inventory #: form 04. Age at admission: d. mo yr. Postal code: - Date of birth: birth: Date of admission: year month day year month day Age at admission: d mo yr Postal code: Ethnic code: Hospital: Gender: 1 = male 2 = female 1 = Impact 2 = Other local, specify: Code

More information

Dilantin (phenytoin) ROBERT A. SCHWARTZ

Dilantin (phenytoin) ROBERT A. SCHWARTZ Dilantin (phenytoin) ROBERT A. SCHWARTZ Bailey & Galyen Attorney in Charge, Mass Tort Litigation Managing Attorney, Houston 18333 Egret Bay Blvd., Suite 120 Houston, Texas 77058 Toll Free: (866) 715-1529

More information

F M S M W D. Age Birth Date Gender Marital Status Cell Phone

F M S M W D. Age Birth Date Gender Marital Status Cell Phone MIDWEST DERMATOLOGY CLINIC, PC Patient Legal Name Last First Middle Initial Today s Date Mailing Address Street City and State Zip Home Telephone F M S M W D. Age Birth Date Gender Marital Status Cell

More information

LECOM Health Ophthalmology

LECOM Health Ophthalmology Patient Name: Date of Birth: New Patient Questionnaire Your answers will be used by your healthcare provider get an accurate history of your medical conditions and ocular concerns. If you are uncomfortable

More information

HEMORRHAGIC BULLOUS HENOCH- SCHONLEIN PURPURA: A CASE REPORT

HEMORRHAGIC BULLOUS HENOCH- SCHONLEIN PURPURA: A CASE REPORT HEMORRHAGIC BULLOUS HENOCH- SCHONLEIN PURPURA: A CASE REPORT Nirmala Ponnuthurai, Sabeera Begum, Lee Bang Rom Paediatric Dermatology Unit, Institute of Paediatric, Hospital Kuala Lumpur, Malaysia Abstract

More information

Hospital-based Dermatopathology. Janis M. Taube, MD Director of Dermatopathology Johns Hopkins University SOM

Hospital-based Dermatopathology. Janis M. Taube, MD Director of Dermatopathology Johns Hopkins University SOM Hospital-based Dermatopathology Janis M. Taube, MD Director of Dermatopathology Johns Hopkins University SOM Overview Drug-eruptions Erythroderma Manifestations of renal disease Blistering disorders Vasculitis/Vasculopathy

More information

Annex I. Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s)

Annex I. Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s) Annex I Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s) 1 Scientific conclusions Taking into account the PRAC Assessment Report on the PSUR(s) for ibuprofen

More information

Bugs and Drugs: What s New in Hypersensitivity Reactions?

Bugs and Drugs: What s New in Hypersensitivity Reactions? Bugs and Drugs: What s New in Hypersensitivity Reactions? Erin Mathes, MD Associate Professor of Dermatology and Pediatrics University of California, San Francisco DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY

More information

PATIENT REGISTRATION INFORMATION DENTAL INSURANCE INFORMATION. Title:! Mr.! Mrs.! Ms.! Miss! Dr. Patient: Last Name: First Name: Middle:

PATIENT REGISTRATION INFORMATION DENTAL INSURANCE INFORMATION. Title:! Mr.! Mrs.! Ms.! Miss! Dr. Patient: Last Name: First Name: Middle: Title:! Mr.! Mrs.! Ms.! Miss! Dr. PATIENT REGISTRATION INFORMATION Patient: Last Name: First Name: Middle: Wish to be called: D.O.B.: / / Age: Sex:!Male! Female SSN: - - Marital Status:! Single!Married!

More information

International IBD Genetics Consortium

International IBD Genetics Consortium International IBD Genetics Consortium PRED4 Case Report Form Please stick study label here On completion, please return to: Claire Bewshea IBD Pharmacogenetics Research Office Ground Floor, Child Health

More information

Case 1. Debridement Cultures Keflex Silvadene

Case 1. Debridement Cultures Keflex Silvadene The Red Breast Beth McLellan, M.D. Assistant Professor Division of Dermatology Albert Einstein College of Medicine Montefiore Medical Center Jacobi Medical Center Case 1 48 year old radiation oncologist

More information

HEALTH SCREENING QUESTIONNAIRE CT Work-up. Donor ID EdgeCell #:

HEALTH SCREENING QUESTIONNAIRE CT Work-up. Donor ID EdgeCell #: HEALTH SCREENING QUESTIONNAIRE CT Work-up Héma-Québec Registre des Donneurs de Cellules Souches 4045 Côte-vertu, St-Laurent, QC, Canada, H4R 2W7 Tél : + 514-832-1031 Fax : + 514-832-0266 www.hema-quebec.qc.ca

More information

Cutanous Manifestation of Lupus Erythematosus. Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university

Cutanous Manifestation of Lupus Erythematosus. Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university Cutanous Manifestation of Lupus Erythematosus Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university A 50-year old lady, who is otherwise healthy, presented to the dermatology clinic with

More information

For Office Use Only: MA complete Date of Visit / / mm/dd/yyyy. This form must be scanned into the medical record. Do not remove from clinic.

For Office Use Only: MA complete Date of Visit / / mm/dd/yyyy. This form must be scanned into the medical record. Do not remove from clinic. For Office Use Only: MA complete Date of Visit / / mm/dd/yyyy This form must be scanned into the medical record. Do not remove from clinic. UWMC Women s Health Care Center & SCCA Women s Cancer Center

More information

Pediatric Dermatology

Pediatric Dermatology Pediatric Dermatology --------- Emergencies & Urgencies Nicholas V. Nguyen, M.D. Director, Pediatric Dermatology Disclosures In the past 12 months, I have had the following financial relationships with

More information

2. Have your symptoms affected your ability to carry out your daily activities? YES NO

2. Have your symptoms affected your ability to carry out your daily activities? YES NO QUESTIONNAIRE Page 1 of 5 Date: Referring MD (Name, Address, Phone Number): Primary Care Physician (Name and Address, Phone Number): Reason for visit: 1. How long have you had symptoms? Describe your symptoms?

More information

A. Erythema multiforme and related diseases

A. Erythema multiforme and related diseases Go Back to the Top To Order, Visit the Purchasing Page for Details Chapter Erythema, Erythroderma (Exfoliative Dermatitis) Erythema is caused by telangiectasia or hyperemia in the papillary and reticular

More information

Radford University School of Nursing GRADUATE HEALTH RECORD FORM

Radford University School of Nursing GRADUATE HEALTH RECORD FORM Revised 6/2018 Radford University School of Nursing GRADUATE HEALTH RECORD FORM The School of Nursing requires a complete Health Record and Certificate of Immunization be completed and signed by a licensed

More information

Patient Last Name First Name Middle Name. Home Address City State Zip. Date of Birth Age Social Security # - - Cell Phone Home Phone Work Phone

Patient Last Name First Name Middle Name. Home Address City State Zip. Date of Birth Age Social Security # - - Cell Phone Home Phone Work Phone Date Patient Last Name First Name Middle Name Gender (circle): Male Female Other: Marital Status (circle): Single Married Divorced Widowed Separated Home Address City State Zip Date of Birth Age Social

More information

We will review the need for continuing treatment with you after 3 months and again after one year.

We will review the need for continuing treatment with you after 3 months and again after one year. Patient Information Drugs for Inflammatory Bowel Disease Adalimumab (Humira) Clinical Nurse Specialist - Allyson Lewis Clinical Nurse Specialist Gareth Lloyd-Ford Clinical Nurse Specialist Lynsey Hook

More information

Pharmacy Prior Authorization

Pharmacy Prior Authorization Pharmacy Prior Authorization MERC CARE PLA (MEDICAID) Humira (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and date. Fax

More information

PATIENT INFORMATION. Date: Patient Name: SS#: Address: City: State: Zip: Phone: (Home) (Work) (Cell)

PATIENT INFORMATION. Date: Patient Name: SS#: Address: City: State: Zip: Phone: (Home) (Work) (Cell) PATIENT INFORMATION Date: Patient Name: SS#: Address: City: State: Zip: Phone: (Home) (Work) (Cell) Email: Gender: Male ( ) Female ( ) Age: Birthdate: Marital Status: Married ( ) Widowed ( ) Single ( )

More information

LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center

LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center Lymphoma is cancer of the lymphatic system. The lymphatic system is made up of organs all over the body that make up and store cells

More information

Name of Recipient: Recipient s DOB (if known) Relationship to Recipient: (Example: mother, father, sister, brother, friend, etc)

Name of Recipient: Recipient s DOB (if known) Relationship to Recipient: (Example: mother, father, sister, brother, friend, etc) The Christ Hospital Health Network DONOR REGISTRATION INFORMATION Phone: 513-585-2493 Fax: 513-585-0433 (Please be advised donor information is needed ONLY to register donor in the Christ Hospital system.

More information

The Old, The New and the Reemerging-HIV Dermatology. Toby Maurer, MD

The Old, The New and the Reemerging-HIV Dermatology. Toby Maurer, MD The Old, The New and the Reemerging-HIV Dermatology Toby Maurer, MD 1 Psoriasis Widespread psoriasis, especially if it was once stable, predicts falling CD4 count?resistance to ART??Non-adherence? Tx:

More information

PATIENT DEMOGRAPHIC SHEET

PATIENT DEMOGRAPHIC SHEET PATIENT DEMOGRAPHIC SHEET Name: Date: Occupation: Gender: Marital Status: Date of Birth: SSN: HOME Street: City: State: Zip: Phone: Cell: Emergency contact : E-Mail Address WORK / SCHOOL Street: City:

More information

This page is for information. Do not submit.

This page is for information. Do not submit. This page is for information. Do not submit. AISH Application - Part B Medical Report Information for Physicians Your patient (the applicant) is applying for the Assured Income for the Severely Handicapped

More information

Part I: Health Form. This form is to be completed by the incoming student by July 15. Name: Date of Birth:

Part I: Health Form. This form is to be completed by the incoming student by July 15. Name: Date of Birth: Part I: Health Form This form is to be completed by the incoming student by July 15. Name: Date of Birth: Last First Middle MM/DD/YYYY Social Security #: Marital Status: ( ) Single ( ) Married ( ) Divorced

More information

Erythematous rash icd 10

Erythematous rash icd 10 Erythematous rash icd 10 Search 2-4-2017 If you re having problems with your gallbladder, your doctor may want you to have a special test called a hepatobiliary iminodiacetic acid (HIDA) scan. International

More information

Member's Name RECOMMENDATION

Member's Name RECOMMENDATION Page 1 of 6 RECOMMENDATION From my evaluation and interpretation of special investigations, I conclude that Mr/s is in good physical condition and able to perform work required for employment in the service

More information

Clinical Pearls Infectious Diseases. Pritish K. Tosh, MD MN ACP Nov 7, [Answers and discussion slides will be posted after the meeting]

Clinical Pearls Infectious Diseases. Pritish K. Tosh, MD MN ACP Nov 7, [Answers and discussion slides will be posted after the meeting] Clinical Pearls Infectious Diseases Pritish K. Tosh, MD MN ACP Nov 7, 2014 [Answers and discussion slides will be posted after the meeting] Case 1 A 33-year-old male with diffuse large B-cell lymphoma

More information

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine Crohn's disease Crohn's disease is an inflammatory condition of the digestive tract that affects children and adults. Common features of Crohn's disease include mouth sores, diarrhea, abdominal pain, weight

More information

Methotrexate for inflammatory bowel disease: what you need to know

Methotrexate for inflammatory bowel disease: what you need to know Methotrexate for inflammatory bowel disease: what you need to know This leaflet aims to answer your questions about taking methotrexate for inflammatory bowel disease (IBD). If you have any questions or

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Ross NA, Chung H-J, Li Q, Andrews JP, Keller MS, Uitto J. Pityriasis rubra pilaris: a case series of patients. Published online March 9, 26. JAMA Dermatol. doi:./jamadermatol.26.9.

More information

What Are the Different Forms?

What Are the Different Forms? SCARRING/CICATRICIAL ALOPECIA Scarring alopecia also known as cicatricial alopecia, refers to a collection of hair loss disorders that may be diagnosed in up to 3% of hair loss patients. It occurs worldwide

More information

SUMMARY. Research hypotheses:

SUMMARY. Research hypotheses: SUMMARY Nephrotic syndrome is one of the most, chronic kidney disease in Egypt. The estimated incidence of nephrotric syndrome ranges between 2-7 childhood cases per 100,000 children per year. Childhood

More information

Patient Information. Spouse or Responsible Party Information. Insurance Information

Patient Information. Spouse or Responsible Party Information. Insurance Information Patient Information Full Name Preferred Name Home Address City, St, Zip Home Phone # E-Mail Address Employed By Work Phone # Occupation Pager/Cell Phone # Male Female Birth Social Security # Married Single

More information

Inflammatory Bowel Disease Medical Exam Questionnaire

Inflammatory Bowel Disease Medical Exam Questionnaire Patient Name: MR: Date: Name DOB / / Age Marital Status Race Gender M / F Height Present Weight Usual Weight Insurance Managed Care Self referral Yes No Yes No Yes No Primary Care Physician Referring Physician

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

Pre-Admission Testing Questionnaire

Pre-Admission Testing Questionnaire Pre-Admission Testing Questionnaire Approximately 2 weeks prior to your surgery date you will receive a telephone call from our Pre-Admission Testing department. During this conversation, a Registered

More information

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING AUTOIMMUNE DISORDERS IN THE ACUTE SETTING Diagnosis and Treatment Goals Aimee Borazanci, MD BNI Neuroimmunology Objectives Give an update on the causes for admission, clinical features, and outcomes of

More information

Big rashes in little patients:

Big rashes in little patients: ! Big rashes in little patients: Severe drug eruptions and cutaneous infections!! Marcia Hogeling, MD, FAAD Assistant Clinical Professor Director, Pediatric Dermatology Division of Dermatology David Geffen

More information

HEALTH SCREENING QUESTIONNAIRE. Work-up. Donor ID EdgeCell #:

HEALTH SCREENING QUESTIONNAIRE. Work-up. Donor ID EdgeCell #: HEALTH SCREENING QUESTIONNAIRE Héma-Québec Registre des Donneurs de Cellules Souches 4045 Côte-vertu, St-Laurent, QC, Canada, H4R 2W7 Tél : + 514-832-1031 Fax : + 514-832-0266 www.hema-quebec.qc.ca CT

More information

PedsCases Podcast Scripts

PedsCases Podcast Scripts PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Drug Allergy. These podcasts are designed to give medical students an overview of key topics in pediatrics. The audio

More information

PATIENT INFORMATION. Name: First Name MI Last Name. Date of Birth: / / Sex: Male / Female / Declined SSN:

PATIENT INFORMATION. Name: First Name MI Last Name. Date of Birth: / / Sex: Male / Female / Declined SSN: PATIENT INFORMATION Name: First Name MI Last Name Date of Birth: / / Sex: Male / Female / Declined SSN: Race: Ethnicity: Hispanic/Latino Not Hispanic/Latino Declined Marital Status: Single Married Divorced/Separated

More information

Name. Address. City State Zip. Home Phone . Cell Phone Can we contact you by text message? Today s Date Date of Birth.

Name. Address. City State Zip. Home Phone  . Cell Phone Can we contact you by text message? Today s Date Date of Birth. Name Address City State Zip Home Phone Email Cell Phone Can we contact you by text message? Today s Date Date of Birth Referred by We re Social! Follow @themedsparpsc on ; themedspa on ; themedsparpsc

More information

An Evidenced-Based Approach to the Adult with a Morbilliform Eruption

An Evidenced-Based Approach to the Adult with a Morbilliform Eruption Relatively An Evidenced-Based Approach to the Adult with a Morbilliform Eruption Ben Kaffenberger, MD Assistant Professor, Dermatology Director, Inpatient Dermatology Consult Service Ohio State University

More information

Dermatology Pearls for Inpatient Medicine. Dr Peter J Green MD FRCPC Professor, Division of Dermatology Dalhousie University

Dermatology Pearls for Inpatient Medicine. Dr Peter J Green MD FRCPC Professor, Division of Dermatology Dalhousie University Dermatology Pearls for Inpatient Medicine Dr Peter J Green MD FRCPC Professor, Division of Dermatology Dalhousie University Objectives 1. Review spectrum of cutaneous manifestations seen with inpatient

More information

PATIENT INFORMATION. Last Name First Name MI. Address. City State Zip. Cell Phone _( ) Home Phone _( ) May we contact you by ?

PATIENT INFORMATION. Last Name First Name MI. Address. City State Zip. Cell Phone _( ) Home Phone _( )  May we contact you by  ? PATIENT INFORMATION date: Last Name First Name MI Address City State Zip Cell Phone _( ) Home Phone _( ) Email May we contact you by email? Yes No Date of Birth Age Marital Status Patient s Occupation

More information

Reducing the burden of squamous cell carcinoma in Fanconi Anemia - Initial study questionnaire -

Reducing the burden of squamous cell carcinoma in Fanconi Anemia - Initial study questionnaire - Reducing the burden of squamous cell carcinoma in Fanconi Anemia - Initial study questionnaire - Today s Date (MM/DD/YYYY): / / Please note: If you do not want to answer a question, leave it blank. (Note

More information

Rayos Prior Authorization Program Summary

Rayos Prior Authorization Program Summary Rayos Prior Authorization Program Summary FDA APPROVED INDICATIONS AND DOSAGE FDA-Approved Indications: 1 Agent Indication Dosage Rayos (prednisone delayedrelease tablet) as an anti-inflammatory or immunosuppressive

More information

Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No

Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No. 0920-0004 STATE USE ONLY DO NOT SEND INFORMATION IN THIS SECTION TO CDC Last Name: First Name: County: Address: City: State,

More information

NEW GYN PATIENT HISTORY FORM (OB PATIENTS, please DO NOT USE THIS FORM. Thanks.)

NEW GYN PATIENT HISTORY FORM (OB PATIENTS, please DO NOT USE THIS FORM. Thanks.) NEW GYN PATIENT HISTORY FORM (OB PATIENTS, please DO NOT USE THIS FORM. Thanks.) TODAY'S DATE Your age DATE OF BIRTH YOUR NAME (Last) (First) (M.I.) REFERRED HERE BY YOUR PAST MEDICAL HISTORY (If YOU have

More information

CPC. Chutika Srisuttiyakorn, M.D. Kobkul Aunhachoke, M.D. Phramongkutklao Hospital Bangkok, Thailand

CPC. Chutika Srisuttiyakorn, M.D. Kobkul Aunhachoke, M.D. Phramongkutklao Hospital Bangkok, Thailand CPC Chutika Srisuttiyakorn, M.D. Kobkul Aunhachoke, M.D. Phramongkutklao Hospital Bangkok, Thailand A 53 year-old woman with fever, facial swelling and rashes on face, trunk and upper extremities for 3

More information

We are an academic institution What does that mean?

We are an academic institution What does that mean? DERMATOLOGY & CUTANEOUS SURGERY We are an academic institution What does that mean? USF Health is an academic institution where future healthcare providers are trained. Below is a description of the different

More information

Past Medical History. Chief Complaint: Appointment Date: Page 1

Past Medical History. Chief Complaint: Appointment Date: Page 1 Appointment Page 1 Chief Complaint: (reason, symptoms, condition or diagnosis that prompts your appointment) Past Medical History EYES Yes No Yes Details Glaucoma EAR, NOSE AND THROAT Hearing difficulty

More information

Past Skin History (Please check the applicable boxes to the patient s history or choose the first box)

Past Skin History (Please check the applicable boxes to the patient s history or choose the first box) Patient: First M.I. Last Date of Birth: Address: City: State: Zip Code: Responsible Billing Party: Social Security #: DOB: Home Work: Mobile: Best Contact number for confirmation calls is: Email (Required):

More information

6140 W Atlantic Avenue * Delray Beach, FL Tel: (561) * (888) 357-DERM * Fax: (561)

6140 W Atlantic Avenue * Delray Beach, FL Tel: (561) * (888) 357-DERM * Fax: (561) Cosmetic Patient Information Today s Date: Reason for visit: Patient Name: (Last) (First) (Middle) Permanent Address (Local): Street City/State/Zip Secondary (Out of State) Address: Street City/State/Zip

More information

DERMATOLOGY AND VENEREOLOGY

DERMATOLOGY AND VENEREOLOGY DECEMBER OI DERMATOLOGY AND VENEREOLOGY Time : llhours Max. Marks : 00 Attempt all questions in order. Each question carries 0 marks. PAPER. I DVD/D/t06t. a. When calculating sample size in a clinical

More information

The Role of Plasmacytoid Dendritic Cells in Psoriasis

The Role of Plasmacytoid Dendritic Cells in Psoriasis 6 ème Journée du Groupe de Recherche sur le Psoriasis Paris, 9 novembre 2012 The Role of Plasmacytoid Dendritic Cells in Psoriasis Dr Curdin Conrad, PD & MER Department of Dermatology Psoriasis: Clinical

More information

Prior Authorization Conditions for Approval of Humira (adalimumab) Website Form Submit request via: Fax

Prior Authorization Conditions for Approval of Humira (adalimumab) Website Form  Submit request via: Fax Prior Authorization Conditions for Approval of Humira (adalimumab) Website Form www.highmarkhealthoptions.com Submit request via: Fax - 1-855-476-4158 All requests for Humira (adalimumab) require a prior

More information

Address: 1. What is your vulvar diagnosis (if known)? 2. What is the main symptom for which you are coming to the Vulvar Mucosal Specialty Clinic?

Address: 1. What is your vulvar diagnosis (if known)? 2. What is the main symptom for which you are coming to the Vulvar Mucosal Specialty Clinic? Referring Physician Address: Phone: Fax: Requirements before your appointment: All records from previous physicians participating in your current condition must be received by the time of your appointment.

More information

MEDICAL HISTORY DO YOU HAVE OR HAVE YOU HAD ANY OF THE FOLLOWING PLEASE CHECK ALL THAT APPLY. Patients s Name Date Yes No Yes No

MEDICAL HISTORY DO YOU HAVE OR HAVE YOU HAD ANY OF THE FOLLOWING PLEASE CHECK ALL THAT APPLY. Patients s Name Date Yes No Yes No MEDICAL HISTORY DO YOU HAVE OR HAVE YOU HAD ANY OF THE FOLLOWING PLEASE CHECK ALL THAT APPLY Patients s Name Date Yes No Yes No Anemia Arthritis Artificial Joints or Heart Valve Asthma Cancer/tumors Chest

More information

Why have I been selected for treatment with adalimumab?

Why have I been selected for treatment with adalimumab? ADALIMUMAB What are the aims of this leaflet? This leaflet has been written to help you understand more about adalimumab (Humira TM ). It tells you what it is, how it works, how it is used to treat skin

More information

Clinical profile of skin diseases in accident and emergency department attenders

Clinical profile of skin diseases in accident and emergency department attenders Hong Kong J. Dermatol. Venereol. (2007) 15, 4-9 Original Article Clinical profile of skin diseases in accident and emergency department attenders CY Chan, KL Kam, CA Graham, TH Rainer, NM Luk Skin problems

More information

Improving outcome of Inflammatory Bowel Disease in children

Improving outcome of Inflammatory Bowel Disease in children Improving outcome of Inflammatory Bowel Disease in children Dinesh Pashankar, MD Pediatric Gastroenterologist Director- Pediatric IBD program Yale University School of Medicine Pediatric Gastroenterology

More information

LRI Children s Hospital. Management of chicken pox exposure in paediatrics

LRI Children s Hospital. Management of chicken pox exposure in paediatrics LRI Children s Hospital Management of chicken pox exposure in paediatrics Staff relevant to: Clinical staff working within the UHL Children s Hospital. Team approval date: October 018 Version: V 3 Revision

More information

MEDICAL ASSESSMENT FOR DEFILEMENT

MEDICAL ASSESSMENT FOR DEFILEMENT Appendix 1: MEDICAL ASSESSMENT FOR DEFILEMENT Hosp No: Name... Age... Date of Birth... Address. Name of doctor examining patient Date and time of assessment Others present. Consent given by HISTORY Date

More information

*

* Introduction Cancer is complex, can have many possible causes, and is increasingly common. For the U.S. population, 1 in 2 males and 1 in 3 females is at risk of developing cancer in their lifetime. The

More information

IN-VITRO FERTILIZATION WITH DONATED OOCYTES COMPREHENSIVE HISTORY OF RECIPIENT COUPLE (HUSBAND)

IN-VITRO FERTILIZATION WITH DONATED OOCYTES COMPREHENSIVE HISTORY OF RECIPIENT COUPLE (HUSBAND) Personal History Name Date of Birth Home Address Home Phone Work Phone Type of Employment Social Security # Medical Insurance Marital Status Religion Highest education degree (high school, college, graduate

More information

MEDICAL RECORD. Last and given name(s)... Personal Identification Number PESEL.. Residence address... Phone number..

MEDICAL RECORD. Last and given name(s)... Personal Identification Number PESEL.. Residence address... Phone number.. MEDICAL RECORD Last and given name(s)... Personal Identification Number PESEL.. Residence address... Phone number The person authorised by the patient to be contacted and receive information concerning

More information

Shingles. A Guide to Understanding Herpes Zoster. By Sarah Weis, PharmD Candidate 2012

Shingles. A Guide to Understanding Herpes Zoster. By Sarah Weis, PharmD Candidate 2012 Shingles A Guide to Understanding Herpes Zoster Information Every Elder Should Know By Sarah Weis, PharmD Candidate 2012 Herpes zoster, also known as shingles, effects up to 1 million people every year

More information

Tuberculosis Procedure ICPr016. Table of Contents

Tuberculosis Procedure ICPr016. Table of Contents Tuberculosis Procedure ICPr016 Table of Contents Tuberculosis Procedure ICPr016... 1 What is Tuberculosis?... 2 Any required definitions/explanations... 2 NHFT... 2 Tuberculosis (TB)... 3 Latent TB...

More information

IPC-PGN 24 Part of NTW(C)23 Infection, Prevention and Control Policy

IPC-PGN 24 Part of NTW(C)23 Infection, Prevention and Control Policy Infection Prevention and Control Practice Guidance Note Management of Parvovirus B19 in healthcare settings V04 Version issued Issue 1 Feb 18 Planned review Feb 2021 IPC-PGN 24 Part of NTW(C)23 Infection,

More information

Emergency Dermatology. Emergency Dermatology

Emergency Dermatology. Emergency Dermatology Emergency Dermatology These are rapidly progressive skin conditions and some are potentially lifethreatening. Early recognition is important to implement prompt supportive care and therapy. Some are drug

More information

Yes No If yes Yes No If yes Yes No If yes Yes No If yes Yes No If yes Yes No If yes. Yes No Yes No

Yes No If yes Yes No If yes Yes No If yes Yes No If yes Yes No If yes Yes No If yes. Yes No Yes No Medical History Although dental personnel primarily treat the area in and around your mouth, your mouth is a part of your entire body. Health problems that you may have, or medication that you may be taking,

More information

Table of Contents. Injectable Gel with 0.3% Lidocaine

Table of Contents. Injectable Gel with 0.3% Lidocaine Patient Brochure Table of Contents About Restylane-L 4 Safety 6 Post-Marketing Surveillance 9 About the Procedure 10 Troubleshooting 11 Injectable Gel with 0.3% Lidocaine 2 3 About Restylane-L Q What is

More information

Pharmacy and Referrals Pharmacy Name, Street Address & Telephone #: Primary Care Physician s Name, Location & Telephone #:

Pharmacy and Referrals Pharmacy Name, Street Address & Telephone #: Primary Care Physician s Name, Location & Telephone #: Patient Registration Please Print Clearly Date: Last Name: First Name: Middle Initial: Sex: Date of Birth: / / Age: Social Security: - - Address: City: State: Zip Code - Circle Preferred Phone Number Home

More information

Pre-Procedure Evaluation

Pre-Procedure Evaluation CellMed Regenerative Medicine 12840 Hillcrest Plaza Drive Suite E104 Dallas, TX 75230 214-442-8908 Pre-Procedure Evaluation Patient Name: Arrival Time: am/pm Sex: Birthdate: Age: Weight: SS#: Patient Address:

More information